CIK 0001745999
- Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-27 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −16,667 | $25.74 | $429K | 85,696 |
| 2026-06-30 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −373 | $34.73 | $13K | 102,363 |
| 2026-04-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −6,700 | $24.58 | $165K | 102,735 |
| 2026-03-31 | Simon Amy Chief Medical Officer | Grant or award | +31,750 | 109,114 | ||
| 2026-01-31 | Simon Amy Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +88,500 | 88,500 | ||
| 2025-12-31 | Simon Amy Chief Medical Officer | Grant or award | +12,500 | 77,364 | ||
| 2025-07-03 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −876 | $20.12 | $18K | 64,864 |
| 2025-07-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −374 | $16.94 | $6K | 65,740 |
| 2025-04-02 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −20,997 | $17.73 | $372K | 65,742 |
| 2025-04-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −9,566 | $18.35 | $176K | 86,739 |
| 2025-03-31 | Simon Amy Chief Medical Officer | Grant or award | +27,500 | 96,305 | ||
| 2025-01-31 | Simon Amy Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2024-07-02 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −748 | $22.95 | $17K | 68,805 |
| 2024-07-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −502 | $23.76 | $12K | 69,553 |
| 2024-04-02 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −16,530 | $30.54 | $505K | 70,060 |
| 2024-04-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −7,157 | $32.13 | $230K | 86,590 |
| 2024-03-31 | Simon Amy Chief Medical Officer | Grant or award | +27,500 | 93,747 | ||
| 2024-01-31 | Simon Amy Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | $24.40 | $1.3M | 55,000 |
| 2023-10-30 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −3,448 | $18.70 | $64K | 65,469 |
| 2023-07-10 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −391 | $30.48 | $12K | 68,917 |
Page 1 of 2 · 24 trades